Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raytel Cardiac Services is a leading provider of remote cardiac monitoring and diagnostic services, specializing in the telephonic and wireless transmission of heart rhythm data. The company offers a comprehensive suite of services, including Holter monitoring, cardiac event monitoring, and pacemaker evaluation, designed to assist physicians in diagnosing and managing patients with suspected arrhythmias. By providing 24/7 monitoring and rapid reporting through its independent diagnostic testing facilities, Raytel enables early intervention and improved clinical outcomes for patients with cardiovascular conditions. In 2007, Raytel Medical Corporation, the parent company, was acquired by Royal Philips Electronics for approximately $110 million to bolster Philips' presence in the home healthcare and remote patient monitoring sectors. The business has since been integrated into Philips' Connected Care portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raytel Cardiac Services.